The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer’s Disease
Publication date
2024-01-16
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Despite decades of intense research, the precise etiology of Alzheimer’s disease (AD) remains unclear. In this hypothesis, we present a new perspective on this matter by identifying carnitine palmitoyl transferase-2 (CPT2) as a central target in AD. CPT2 is an enzyme situated within the inner mitochondrial membrane, playing a crucial role in beta-oxidation of fatty acids. It exhibits high sensitivity to hydrogen peroxide. This sensitivity holds relevance for the etiology of AD, as all major risk factors for the disease share a commonality in producing an excess of hydrogen peroxide right at this very mitochondrial membrane. We will explain the high sensitivity of CPT2 to hydrogen peroxide and elucidate how the resulting inhibition of CPT2 can lead to the characteristic phenotype of AD, thus clarifying its central role in the disease’s etiology. This insight holds promise for the development of therapies for AD which can be implemented immediately.
Keywords
Alzheimer’s disease, AMP-kinase pathway dependent integrated stress response, carnitine palmitoyl transferase 2, CPT2, hydrogen peroxide, hypoxia, longevity, radical oxygen species, Taverne, General Neuroscience, Clinical Psychology, Geriatrics and Gerontology, Psychiatry and Mental health, SDG 3 - Good Health and Well-being
Citation
Keizer, H G, Brands, R, Oosting, R S & Seinen, W 2024, 'The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer’s Disease', Journal of Alzheimer's Disease, vol. 97, no. 2, pp. 553-558. https://doi.org/10.3233/JAD-230991